Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Krebs Biochemicals & Industries Limited
KREBSBIO | NSE
44.44
INR4.69
11.80%
KREBSBIO | NSE
Loading StockChartView...
About Krebs Biochemicals & Industries Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
01/04/2026
Close
44.44
Open
43.00
High
47.65
Low
40.00
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine agriculture and industry fields. Its products include androstenedione lovastatin and simvastatin which are used for anti-cholesterol and steroid intermediate applications. The company is also developing various products including amlodipine cetirizine orlistat serratiopepetidase telmisartan and phenylephrine for anti-hypertension anti-histamine anti-obesity anti-inflammatory and cold and cough applications. In addition it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad India.
View LessKREBSBIO | NSE
Risk
74.6
Sharpe
-0.97
Luna's Score
54/100
Recommendation
Hold
Luna says (KREBSBIO | NSE)
What's Working
Strength based on increasing price with high volume
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Price Below SMA10D
High Short-term Volatility
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
Loading RiskMeterView...
10 days
97.3%1 month
74.6%3 months
57.0%6 months
45.1%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-1.62
Debt to assets
1.09
Ent. to EBITDA
-16.12
Ent. to rev.
8.28
PEG
-
Other Fundamentals
EBITDA
-77.92M
MarketCap
954.82M
MarketCap(USD)
10.26M
Div. yield
-
Op. margin
-29.89
Erngs. growth
-
Rev. growth
21.80
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
12.57
Range1M
18.65
Range3M
34.68
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
1.02
Price X volume
388.58K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -16.12 | 24.85 | Cheaper |
| Ent. to Revenue | 8.28 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | - | 6.83 | - |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 57.02 | 42.17 | Riskier |
| Debt to Equity | -1.62 | 0.35 | Cheaper |
| Debt to Assets | 1.09 | 0.17 | Expensive |
| Market Cap | 954.82M | 290.82B | Emerging |
